Study Finds Drug Ads Can Influence AI Treatment Recommendations
A Mount Sinai study in The Lancet Digital Health tested 12 AI models from Google, OpenAI, Anthropic and others, finding a labeled drug ad before a clinical case shifted treatment choices. Across 33 scenarios, the advertised drug was chosen in 47.6% of responses with an ad versus 35% without; in four cases the rate moved from 0% to 100%. Authors warn answers can look medically sound while preferences are swayed.